Module

Clinical Strategies for Initiation of Antiretroviral Therapy

Source: HIV/AIDS Annual Update 2008

Clinical Strategies for Initiation of Antiretroviral Therapy

Faculty:
Joel E. Gallant, MD, MPH

CME CREDIT INFORMATION

Release Date: 05/21/08

Expiration Date: 05/20/09

Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.3 contact hours (0.13 CEUs)

Registered Nurses: 1.3 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the rationale for earlier vs later initiation of antiretroviral therapy
Recount current treatment guidelines for first-line antiretroviral regimens
Describe initial therapy modifications appropriate for special populations
Explain data on newer agents in treatment-naive populations that may support future use of these agents for first-line therapy

Topics covered include:

Introduction
When to Start
What to Start With
Ritonavir-Boosted PI Plus 2 NRTIs
NNRTI Plus 2 NRTIs
Unboosted PI Plus 2 NRTIs
Choice of NRTIs in Initial Regimen
Use of Integrase Inhibitors and CCR5 Antagonists in Treatment-Naive Patients
Choice of Initial Therapy in Special Populations
Summary—Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.